Veno Occlusive Disease, Hepatic Completed Phase 3 Trials for Defibrotide (DB04932)

Also known as: Hepatic Veno-Occlusive Disease / Venoocclusive liver disease / Veno-occlusive disease of liver / Veno-occlusive liver disease / Veno-occlusive disease of the liver (disorder) / Venoocclusive syndrome of the liver / Sinusoidal obstruction syndrome

IndicationStatusPhase
DBCOND0105973 (Veno Occlusive Disease, Hepatic)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00628498Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND StudyTreatment